AI assistant
Sending…
Tharimmune, Inc. — Director's Dealing 2026
Feb 11, 2026
34824_dirs_2026-02-11_c3d50b02-0d77-4809-b046-b66188219ac5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Tharimmune, Inc. (THAR)
CIK: 0001861657
Period of Report: 2025-12-10
Reporting Person: Asbury Jacob (Chief Financial Officer)
More from Tharimmune, Inc.
Interim / Quarterly Report
2026
May 13
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 3
Regulatory Filings
2026
Mar 3
Regulatory Filings
2026
Feb 18
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Regulatory Filings
2026
Feb 6